Pacific Biosciences Of Stock Price on April 2, 2024
| PACB Stock | USD 1.83 0.10 5.18% |
Below is the normalized historical share price chart for Pacific Biosciences of extending back to October 27, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pacific Biosciences stands at 1.83, as last reported on the 4th of December, with the highest price reaching 1.91 and the lowest price hitting 1.80 during the day.
If you're considering investing in Pacific Stock, it is important to understand the factors that can impact its price. Pacific Biosciences appears to be risky, given 3 months investment horizon. Pacific Biosciences maintains Sharpe Ratio (i.e., Efficiency) of 0.0945, which implies the firm had a 0.0945% return per unit of risk over the last 3 months. By analyzing Pacific Biosciences' technical indicators, you can evaluate if the expected return of 0.63% is justified by implied risk. Please evaluate Pacific Biosciences' Semi Deviation of 5.36, coefficient of variation of 1022.38, and Risk Adjusted Performance of 0.0835 to confirm if our risk estimates are consistent with your expectations.
At present, Pacific Biosciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 736.4 M, whereas Common Stock Total Equity is forecasted to decline to about 189 K. . At present, Pacific Biosciences' Price Book Value Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 1.02, whereas Price To Sales Ratio is forecasted to decline to 11.79. Pacific Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of October 2010 | 200 Day MA 2.2351 | 50 Day MA 1.908 | Beta 2.009 |
Pacific |
Sharpe Ratio = 0.0945
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PACB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.68 actual daily | 59 59% of assets are less volatile |
Expected Return
| 0.63 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Pacific Biosciences is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pacific Biosciences by adding it to a well-diversified portfolio.
Price Book 1.2536 | Enterprise Value Ebitda (4.15) | Price Sales 3.1106 | Shares Float 272.2 M | Wall Street Target Price 3.0208 |
Related Headline
Twist Bioscience Headline on 2nd of April 2024
Filed transaction by Twist Bioscience Corp Officer: Svp Of Human Resources. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Pacific Biosciences Valuation on April 2, 2024
It is possible to determine the worth of Pacific Biosciences on a given historical date. On April 2, 2024 Pacific was worth 3.6 at the beginning of the trading date compared to the closed value of 3.41. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pacific Biosciences stock. Still, in general, we apply an absolute valuation method to find Pacific Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pacific Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pacific Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 3.83 | 3.85 | 3.58 | 3.65 | 6,081,929 | |
04/02/2024 | 3.60 | 3.60 | 3.37 | 3.41 | 7,983,250 |
| 3.37 | 3.52 | 3.21 | 3.36 | 7,664,101 |
| Backtest Pacific Biosciences | | | Pacific Biosciences History | | | Pacific Biosciences Valuation | Previous | Next |
Pacific Biosciences Trading Date Momentum on April 2, 2024
| On April 03 2024 Pacific Biosciences of was traded for 3.36 at the closing time. The top price for the day was 3.52 and the lowest listed price was 3.21 . The trading volume for the day was 7.7 M. The trading history from April 3, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.47% . The trading delta at closing time against the current closing price is 2.93% . |
Pacific Biosciences Fundamentals Correlations and Trends
By evaluating Pacific Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pacific Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pacific financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pacific Biosciences Stock history
Pacific Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pacific is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pacific Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pacific Biosciences stock prices may prove useful in developing a viable investing in Pacific Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 253.6 M | 266.3 M | |
| Net Loss | -282.8 M | -268.7 M |
Pacific Biosciences Quarterly Net Working Capital |
|
Pacific Biosciences Stock Technical Analysis
Pacific Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pacific Biosciences Period Price Range
Low | December 4, 2024
| High |
0.00 | 0.00 |
Pacific Biosciences of cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pacific Biosciences December 4, 2024 Market Strength
Market strength indicators help investors to evaluate how Pacific Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pacific Biosciences shares will generate the highest return on investment. By undertsting and applying Pacific Biosciences stock market strength indicators, traders can identify Pacific Biosciences of entry and exit signals to maximize returns
Pacific Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pacific Biosciences' price direction in advance. Along with the technical and fundamental analysis of Pacific Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pacific to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0835 | |||
| Jensen Alpha | 0.3929 | |||
| Total Risk Alpha | (0.26) | |||
| Sortino Ratio | 0.0911 | |||
| Treynor Ratio | 0.2689 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Pacific Stock analysis
When running Pacific Biosciences' price analysis, check to measure Pacific Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacific Biosciences is operating at the current time. Most of Pacific Biosciences' value examination focuses on studying past and present price action to predict the probability of Pacific Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacific Biosciences' price. Additionally, you may evaluate how the addition of Pacific Biosciences to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |